As critical mediators in anti-tumor immunity, plasma cells are capable of producing antibodies and CD4+ T cells secrete diverse cytokines that enhance humoral and cellular immunity (Borst et al., 2018; Sharonov et al., 2020). This evidence concerns the gene CD4 and neoplasm.